Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 27, 2010, Pages 12210-12215

  Santanam, Urmila ^a   Zanesi, Nicola ^a   Efanov, Alexey ^a   Costinean, Stefan ^a   Palamarchuk, Alexey ^a   Hagan, John P ^a   Volinia, Stefano ^a   Alder, Hansjuerg ^a   Rassenti, Laura ^b   Kipps, Thomas ^b   Croce, Carlo M ^a   Pekarsky, Yuri ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

microRNA; Mouse models

Indexed keywords

CARRIER PROTEIN; CD5 ANTIGEN; PROTEIN MIR 29; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; UPREGULATION;

ANIMALS; ANTIGENS, CD19; ANTIGENS, CD5; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; MICE; MICE, TRANSGENIC; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN;

MUS; MUS MUSCULUS;

EID: 77955435090     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1007186107     Document Type: Article

References (34)

1. SgambatiM, Linet M, Devesa S (2001) Chronic lymphocytic leukemia, epidemiological, familial, and genetic aspects. Chronic Lymphocytic Leukemias, ed Cheson B (Marcel Dekker, Inc., New York) 2nd Ed, pp 33-62.
2. Bullrich F, Croce C (2001) Molecular biology of chronic lymphocytic leukemia. Chronic Lymphocytic Leukemias, ed Cheson B (Marcel Dekker, Inc., New York) 2nd Ed, pp 9-32.
3. Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Calin GA, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101:11755-11760.
5. Volinia S, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261.
6. Döhner H, et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910-1916. (Pubitemid 32064784)
7. Calin GA, et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524-15529.
8. Cimmino A, et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944-13949.
9. Pekarsky Y, et al. (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66:11590-11593.
10. Herling M, et al. (2006) TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 20:280-285.
11. Zhao JJ, et al. (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115:2630-2639.
12. Mott JL, Kobayashi S, Bronk SF, Gores GJ (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26:6133-6140.
13. Gebeshuber CA, Zatloukal K, Martinez J (2009) miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10:400-405.
14. Han YC, et al. (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 207:475-489.
15. Bichi R, et al. (2002) Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 99:6955-6960.
16. Chiorazzi N (2007) Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells. Best Pract Res Clin Haematol 20:399-413.
17. Messmer BT, et al. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 115:755-764.
18. Sieklucka M, et al. (2008) Apoptosis in B-CLL: The relationship between higher ex vivo spontaneous apoptosis before treatment in III-IV Rai stage patients and poor outcome. Oncol Rep 19:1611-1620.
19. Caligaris-Cappio F, Hamblin TJ (1999) B-cell chronic lymphocytic leukemia: A bird of a different feather. J Clin Oncol 17:399-408.
20. Zanesi N, et al. (2006) Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice. Cancer Res 66:915-920.
21. Efanov A, et al. (2010) CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. Leukemia 24: 970-975.
22. Fabbri M, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104: 15805-15810.
23. Horikoshi N, Cong J, Kley N, Shenk T (1999) Isolation of differentially expressed cDNAs from p53-dependent apoptotic cells: Activation of the human homologue of the Drosophila peroxidasin gene. Biochem Biophys Res Commun 261:864-869.
24. Desmond JC, et al. (2007) Discovery of epigenetically silenced genes in acute myeloid leukemias. Leukemia 21:1026-1034.
25. van Doorn R, et al. (2005) Epigenetic profiling of cutaneous T-cell lymphoma: Promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 23:3886-3896.
26. Himmelfarb M, et al. (2004) ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer. Cancer Lett 204:69-77.
27. Costinean S, et al. (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103: 7024-7029.
28. Klein U, et al. (2010) The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17:28-40.
29. Zanesi N, Pekarsky Y, Trapasso F, Calin G, Croce C (2010) MicroRNAs in mouse models of lymphoid malignancies. J Nucleic Acids Invest 1:36-40.
30. Garzon R, et al. (2009) MicroRNA 29b functions in acute myeloid leukemia. Blood 114: 5331-5341.
31. Garzon R, et al. (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 105:3945-3950.
32. Palamarchuk A, et al. (2010) 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 115:3916-3922.
33. Palamarchuk A, et al. (2006) Tal1 transgenic expression reveals absence of B lymphocytes. Cancer Res 66:6014-6017.
34. Pekarsky Y, et al. (2008) Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci USA 105:19643-19648.